{
    "clinical_study": {
        "@rank": "26782", 
        "arm_group": [
            {
                "arm_group_label": "Indomethacin patch", 
                "arm_group_type": "Experimental", 
                "description": "Indomethacin patch to be applied on the sprained ankle twice a day (BID)."
            }, 
            {
                "arm_group_label": "Placebo patch", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo patch to be applied on the sprained ankle BID."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will investigate the efficacy of the Indomethacin patch in pain relief of ankle\n      sprain in adult patients, compared to a placebo patch"
        }, 
        "brief_title": "Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ankle Sprain", 
        "condition_browse": {
            "mesh_term": [
                "Sprains and Strains", 
                "Ankle Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) which reduces pain, fever,\n      stiffness and swelling in acute skeletal musculature injuries involving joints. However,\n      oral Indomethacin formulations predisposes for some systemic side effects. To avoid the\n      systemic side effects of oral Indomethacin, a topical Indomethacin formulations have been\n      developed and approved in some countries as an Over the counter product. Present study is to\n      investigate the efficacy of the Indomethacin patch in pain relief of ankle sprain in adult\n      patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participant with Grade I or Grade II acute sprain of the lateral ankle within 24\n             hours before screening visit\n\n          -  Participant with self-assessed pain intensity score after movement (5 steps) at the\n             site of the ankle sprain that is >= 5 as measured on a 0-10 NRS rating.\n\n          -  Participant with a peri-malleolar edema (sub-malleolar perimeter difference of >=20mm\n             between injured and uninjured ankle)\n\n        Exclusion Criteria:\n\n          -  Known or suspected intolerance or hypersensitivity to the study materials (or closely\n             related compounds) or any of their stated ingredients.\n\n          -  Participant who had medication that could interfere with the subject's perception of\n             pain since experiencing ankle sprain.\n\n          -  Pregnancy , Breast Feeding and  Substance Abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "270", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957215", 
            "org_study_id": "RH01778"
        }, 
        "intervention": [
            {
                "arm_group_label": "Indomethacin patch", 
                "description": "Topical indomethacin", 
                "intervention_name": "Indomethacin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo patch", 
                "description": "Placebo patch", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Indomethacin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2014", 
        "location": [
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Changzhou", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "213003"
                    }, 
                    "name": "Changzhou NO.2 People?s Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "210009"
                    }, 
                    "name": "Zhongda Hospital Southeast University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Suzhou", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "215006"
                    }, 
                    "name": "The First Affiliated Hospital of Soochow University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200092"
                    }, 
                    "name": "Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200020"
                    }, 
                    "name": "Ruijin Hospital Luwan Branch"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200031"
                    }, 
                    "name": "Shanghai Xuhui Centre Hospital"
                }, 
                "status": "Suspended"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200120"
                    }, 
                    "name": "Shanghai East Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200072"
                    }, 
                    "name": "Shanghai Tenth People?s Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "201620"
                    }, 
                    "name": "Shanghai First People?s Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "info@GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200025"
                    }, 
                    "name": "Shanghai Ruijin Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Clinical Study to Assess the Efficacy of Pain Relief of Topical Indomethacin Patch Over Placebo in Ankle Sprain Patients", 
        "overall_contact": {
            "email": "GSKClinicalSupportHD@gsk.com", 
            "last_name": "US GSK Clinical Trials Call Center", 
            "phone": "877-379-3718"
        }, 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assessing efficacy of Indomethacin patch in comparison with placebo patch measured by SPID for pain on movement during the 48 hour time interval.", 
            "measure": "Sum of Pain Intensity Difference (SPID)", 
            "safety_issue": "No", 
            "time_frame": "From treatment Day 1 to Day 3"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957215"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "PRS to be assessed.", 
                "measure": "Pain Relief Score (PRS)", 
                "safety_issue": "No", 
                "time_frame": "PRS to be assessed Day 1-end of study"
            }, 
            {
                "description": "NRS for pain on movement (walking 5 steps on flat surface) to be assessed.", 
                "measure": "Numerical Rating Scale (NRS) for pain", 
                "safety_issue": "No", 
                "time_frame": "NRS on movement Day 1-end of study"
            }, 
            {
                "description": "Measuring the mean changes from baseline of NRS at rest twice daily (in the morning and afternoon) from treatment day 1 to day 7 between treatment groups.", 
                "measure": "Change from baseline in NRS at rest", 
                "safety_issue": "No", 
                "time_frame": "NRS at rest Day1-Day7"
            }, 
            {
                "description": "Time to reach PRS=1; \"A little or perceptible pain relief\".", 
                "measure": "Time to onset of pain relief", 
                "safety_issue": "No", 
                "time_frame": "Day 1-2 ,Day 1-3, Day 1-7"
            }, 
            {
                "description": "SPID (1-2days), SPID (1-7days) to be assessed.", 
                "measure": "SPID", 
                "safety_issue": "No", 
                "time_frame": "Day 1-2 ,Day 1-3, Day 1-7"
            }, 
            {
                "description": "SPRID to be assessed", 
                "measure": "Sum of Pain Intensity Difference and Pain Relief (SPRID)", 
                "safety_issue": "No", 
                "time_frame": "Day 1-2 ,Day 1-3, Day 1-7"
            }, 
            {
                "description": "TOTPAR at treatment 1 to 2, 1 to 3, and 1 to 7 days time period between treatment groups.", 
                "measure": "Total Pain Relief (TOTPAR)", 
                "safety_issue": "No", 
                "time_frame": "Day 1-2 ,Day 1-3, Day 1-7"
            }, 
            {
                "description": "Rescue medication use to be monitored", 
                "measure": "Time to rescue medication", 
                "safety_issue": "No", 
                "time_frame": "Day 1 to Day 14"
            }, 
            {
                "description": "Global Assessment to be accessed", 
                "measure": "Global  Assessment", 
                "safety_issue": "No", 
                "time_frame": "End of study"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "collaborator": {
                "agency": "Rundo International Pharmaceutical Research & Development Co.,Ltd.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}